Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mason Hawkins is Doubling Down on This Hotel Company

Southeastern Asset Management, a Tennessee-based investment management firm ran by Mason Hawkins, has doubled its position in InterContinental Hotels Group PLC (NYSE:IHG). InterContinental is a manager and franchiser of hotels and resorts, operating all over the world. The company operates such brands as InterContinental Hotels & Resorts, Crowne Plaza Hotels & Resorts, Holiday Inn Hotels and Resorts, Holiday Inn Express, Staybridge Suites and Candlewood Suites.

Mason Hawkins

Mason first took interest in InterContinental back in October 2011, when Southeastern initiated a new position in the hotel company. At the time, the stake equaled 11.1% and the stock was trading between $16-$18 per share. It now trades north of $25. Since Mason and Southeastern announced their initial position in October 2011, the stock has steadily risen. Along the way, Mason had trimmed his firm’s position in the company from the initial 32.2 million shares he invested, to 13.2 million by the end of the second quarter of 2012.

The most recent purchase by Southeastern raises its stake in InterContinental to 9.4%, effectively increasing the fund’s position twofold, from the 13.2 million shares it owned at the end of Q2 to 27.5 million shares it currently owns. Other notable hedge funds with small stakes in InterContinental include D.E. Shaw & Co. and SAC Capital Advisors, and you can also view all funds that own the company by clicking here.

InterContinental’s revenue and earnings expectations show strong growth prospects over the next few years. The consensus estimates are that revenues will reach $1.86 billion for 2012 and $1.96 billion for 2013, versus revenue of $1.77 billion in 2011. EPS estimates have been revised upward and are now expected to be $1.34 for 2012 and $1.51 for 2013, versus $1.27 for 2011. InterContinental’s international exposure should help insulate it against a further slowdown in the U.S. At the close of the second quarter of 2012, InterContinental was already showing promise in international markets, with an 11% increase in European segment revenues and 14% in its China segment.

The competitive environment for hotels is saturated, with InterContinental competing with the likes of Hyatt Hotels Corporation (NYSE:H), Marriott International, Inc. (NYSE:MAR), Choice Hotels International, Inc. (NYSE:CHH) and Wyndham Worldwide Corporation (NYSE:WYN), just to name a few. On a Price-to-Earnings basis, InterContinental trades below its competitors, with a trailing P/E of 13, while Hyatt trades at a 58 P/E, Marriott at a 64 P/E, Choice at a 16 P/E, and Wyndham at a 21 P/E.

The catalyst to drive InterContinental’s stock higher will be its ability to execute its aggressive expansion plans. InterContinental wants to diffuse across Indonesia with two entirely new hotel brands, which the company then plans to take across Southeast Asia. Additionally, InterContinental has placed a particular importance on China, as it will have established ten new hotels in the country by the end of the year.

The last time Southeastern took such a commanding stake in InterContinental, the company’s stock rose by nearly 40% over the next six months. We believe that Mason Hawkins and Southeastern are very confident that InterContinental can capitalize on its expansion efforts in a cost-effective manner, just as it has managed to do since the firm made its initial investment back in October 2011.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!